SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-068637
Filing Date
2022-11-02
Accepted
2022-11-02 16:00:44
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_inmunebio.htm   iXBRL 10-Q 573397
2 CERTIFICATION f10q0922ex31-1_inmunebio.htm EX-31.1 10348
3 CERTIFICATION f10q0922ex31-2_inmunebio.htm EX-31.2 10351
4 CERTIFICATION f10q0922ex32-1_inmunebio.htm EX-32.1 4738
5 CERTIFICATION f10q0922ex32-2_inmunebio.htm EX-32.2 4791
  Complete submission text file 0001213900-22-068637.txt   3805294

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20220930.xsd EX-101.SCH 57879
7 XBRL CALCULATION FILE inmb-20220930_cal.xml EX-101.CAL 30757
8 XBRL DEFINITION FILE inmb-20220930_def.xml EX-101.DEF 206032
9 XBRL LABEL FILE inmb-20220930_lab.xml EX-101.LAB 457792
10 XBRL PRESENTATION FILE inmb-20220930_pre.xml EX-101.PRE 218961
57 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_inmunebio_htm.xml XML 351942
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 221353889
SIC: 2836 Biological Products, (No Diagnostic Substances)